Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors

Lisa-Maria  Rečnik; Robert J. Thatcher; Shahida Mallah; Craig P. Butts; Graham L.  Collingridge; Elek Molnár; David E.  Jane; Christine L.  Willis

doi:10.1039/D1OB01653A

Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors

Lisa-Maria Rečnik, Robert J. Thatcher, Shahida Mallah, Craig P. Butts, Graham L. Collingridge, Elek Molnár, David E. Jane, Christine L. Willis

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

(−)-Arctigenin and a series of new analogues have been synthesised and then tested for their potential as AMPA and kainate receptor antagonists of human homomeric GluA1 and GluK2 receptors expressed in HEK293 cells using a Ca2+ influx assay. In general, these compounds showed antagonist activity at both receptors with greater activity evident at AMPARs. Schild analysis indicates that a spirocyclic analogue 6c acts as a non-competitive antagonist. Molecular docking studies in which 6c was docked into the X-ray crystal structure of the GluA2 tetramer suggest that (−)-arctigenin and its analogues bind in the transmembrane domain in a similar manner to the known AMPA receptor non-competitive antagonists GYKI53655 and the antiepileptic drug perampanel. The arctigenin derivatives described herein may serve as novel leads for the development of drugs for the treatment of epilepsy.

Original language	English
Pages (from-to)	9154-9162
Number of pages	9
Journal	Organic and Biomolecular Chemistry
Volume	19
Issue number	42
Early online date	13 Oct 2021
DOIs	https://doi.org/10.1039/D1OB01653A
Publication status	Published - 14 Nov 2021
Externally published	Yes

Funder

Funding Information: We are grateful to the Bristol Chemical Synthesis Doctoral Training Centre funded by EPSRC (EP/G036764/1) for a studentship (L-MR) and ERC grant (HippoKAR) for financial support for RJT. EM and DEJ were supported by the Biotechnology and Biological Sciences Research Council (Grant BB/J015938/1) and GLC by CIHR (Canadian Institute of Health Research) award FDN154276. SM was a Shah Abdul Latif University-funded PhD student.

ASJC Scopus subject areas

Biochemistry
Physical and Theoretical Chemistry
Organic Chemistry

Access to Document

10.1039/D1OB01653A

Cite this

@article{85f81c8a5f1d40caa5b4eb472ce19de1,

title = "Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors",

abstract = "(−)-Arctigenin and a series of new analogues have been synthesised and then tested for their potential as AMPA and kainate receptor antagonists of human homomeric GluA1 and GluK2 receptors expressed in HEK293 cells using a Ca2+ influx assay. In general, these compounds showed antagonist activity at both receptors with greater activity evident at AMPARs. Schild analysis indicates that a spirocyclic analogue 6c acts as a non-competitive antagonist. Molecular docking studies in which 6c was docked into the X-ray crystal structure of the GluA2 tetramer suggest that (−)-arctigenin and its analogues bind in the transmembrane domain in a similar manner to the known AMPA receptor non-competitive antagonists GYKI53655 and the antiepileptic drug perampanel. The arctigenin derivatives described herein may serve as novel leads for the development of drugs for the treatment of epilepsy.",

author = "Lisa-Maria Re{\v c}nik and Thatcher, {Robert J.} and Shahida Mallah and Butts, {Craig P.} and Collingridge, {Graham L.} and Elek Moln{\'a}r and Jane, {David E.} and Willis, {Christine L.}",

year = "2021",

month = nov,

day = "14",

doi = "10.1039/D1OB01653A",

language = "English",

volume = "19",

pages = "9154--9162",

journal = "Organic and Biomolecular Chemistry",

number = "42",

}

TY - JOUR

T1 - Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors

AU - Rečnik, Lisa-Maria

AU - Thatcher, Robert J.

AU - Mallah, Shahida

AU - Butts, Craig P.

AU - Collingridge, Graham L.

AU - Molnár, Elek

AU - Jane, David E.

AU - Willis, Christine L.

PY - 2021/11/14

Y1 - 2021/11/14

N2 - (−)-Arctigenin and a series of new analogues have been synthesised and then tested for their potential as AMPA and kainate receptor antagonists of human homomeric GluA1 and GluK2 receptors expressed in HEK293 cells using a Ca2+ influx assay. In general, these compounds showed antagonist activity at both receptors with greater activity evident at AMPARs. Schild analysis indicates that a spirocyclic analogue 6c acts as a non-competitive antagonist. Molecular docking studies in which 6c was docked into the X-ray crystal structure of the GluA2 tetramer suggest that (−)-arctigenin and its analogues bind in the transmembrane domain in a similar manner to the known AMPA receptor non-competitive antagonists GYKI53655 and the antiepileptic drug perampanel. The arctigenin derivatives described herein may serve as novel leads for the development of drugs for the treatment of epilepsy.

AB - (−)-Arctigenin and a series of new analogues have been synthesised and then tested for their potential as AMPA and kainate receptor antagonists of human homomeric GluA1 and GluK2 receptors expressed in HEK293 cells using a Ca2+ influx assay. In general, these compounds showed antagonist activity at both receptors with greater activity evident at AMPARs. Schild analysis indicates that a spirocyclic analogue 6c acts as a non-competitive antagonist. Molecular docking studies in which 6c was docked into the X-ray crystal structure of the GluA2 tetramer suggest that (−)-arctigenin and its analogues bind in the transmembrane domain in a similar manner to the known AMPA receptor non-competitive antagonists GYKI53655 and the antiepileptic drug perampanel. The arctigenin derivatives described herein may serve as novel leads for the development of drugs for the treatment of epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=85118801855&partnerID=8YFLogxK

U2 - 10.1039/D1OB01653A

DO - 10.1039/D1OB01653A

M3 - Article

VL - 19

SP - 9154

EP - 9162

JO - Organic and Biomolecular Chemistry

JF - Organic and Biomolecular Chemistry

IS - 42

ER -

Synthesis and pharmacological characterisation of arctigenin analogues as antagonists of AMPA and kainate receptors

Abstract

Funder

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this